Nancy Harold

705 total citations
27 papers, 502 citations indexed

About

Nancy Harold is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Nancy Harold has authored 27 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Nancy Harold's work include Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (9 papers) and Neutropenia and Cancer Infections (7 papers). Nancy Harold is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (9 papers) and Neutropenia and Cancer Infections (7 papers). Nancy Harold collaborates with scholars based in United States, Malaysia and Ukraine. Nancy Harold's co-authors include Jean L. Grem, Mary Quinn, Rebecca R. Thomas, Barbara Schüler, Gregory D. Leonard, Suzanne Fioravanti, M. A. Wright, William L. Dahut, Brian P. Monahan and Chris H. Takimoto and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Nancy Harold

27 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy Harold United States	12	360	197	81	68	63	27	502
Fulvio Brema Italy	12	388 1.1×	79 0.4×	67 0.8×	86 1.3×	48 0.8×	36	562
Anatole Cessot France	12	328 0.9×	137 0.7×	195 2.4×	72 1.1×	66 1.0×	30	562
Ayako Mitsuma Japan	13	294 0.8×	189 1.0×	122 1.5×	63 0.9×	25 0.4×	43	532
Bill L. Tranum United States	11	233 0.6×	46 0.2×	100 1.2×	57 0.8×	35 0.6×	20	427
Qiong Zhao China	14	299 0.8×	145 0.7×	196 2.4×	38 0.6×	15 0.2×	28	503
Simone M. Mrotzek Germany	10	174 0.5×	80 0.4×	66 0.8×	15 0.2×	17 0.3×	15	414
Joseph Corkery United States	8	74 0.2×	91 0.5×	48 0.6×	73 1.1×	10 0.2×	8	331
Leona Rudinskas Canada	8	267 0.7×	95 0.5×	69 0.9×	341 5.0×	14 0.2×	11	584
Candice Jamois Switzerland	11	125 0.3×	112 0.6×	34 0.4×	39 0.6×	6 0.1×	30	374
Emma Zattarin Italy	11	291 0.8×	114 0.6×	174 2.1×	11 0.2×	13 0.2×	41	500

Countries citing papers authored by Nancy Harold

Since Specialization

Citations

This map shows the geographic impact of Nancy Harold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Harold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Harold more than expected).

Fields of papers citing papers by Nancy Harold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Harold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Harold. The network helps show where Nancy Harold may publish in the future.

Co-authorship network of co-authors of Nancy Harold

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Harold. A scholar is included among the top collaborators of Nancy Harold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Harold. Nancy Harold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karzai, Fatima, Ravi A. Madan, Marc R. Theoret, et al.. (2015). Cabozantinib (C) plus docetaxel (D) and prednisone (P) in metastatic castrate-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 33(7_suppl). 235–235. 2 indexed citations

Karzai, Fatima, Andrea B. Apolo, Liang Cao, et al.. (2014). A phase I study of TRC 105 anti‐endoglin ( CD 105) antibody in metastatic castration‐resistant prostate cancer. British Journal of Urology. 116(4). 546–555. 54 indexed citations

Morris, John C., Gabriela R. Rossi, Nancy Harold, et al.. (2013). Potential chemo-sensitization effect of tergenpumatucel-L immunotherapy in treated patients with advanced non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 31(15_suppl). 8094–8094. 13 indexed citations

Morris, Joel, Deborah E. Citrin, Liesl Nottingham, et al.. (2010). Phase I study of proteasome inhibitor bortezomib (B) concurrent with re-irradiation therapy (re-RT) for recurrent squamous cell carcinoma of the head and neck (SCCHN).. Journal of Clinical Oncology. 28(15_suppl). 2603–2603. 3 indexed citations

Waes, Carter Van, Clint Allen, Deborah E. Citrin, et al.. (2009). Molecular and Clinical Responses in a Pilot Study of Gefitinib With Paclitaxel and Radiation in Locally Advanced Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 77(2). 447–454. 26 indexed citations

Leonard, Gregory D., M. A. Wright, Mary Quinn, et al.. (2005). Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. BMC Cancer. 5(1). 116–116. 135 indexed citations

Wright, M. A., Gregory D. Leonard, Dat Nguyen, et al.. (2005). A Phase I Pharmacologic and Pharmacogenetic Trial of Sequential 24-Hour Infusion of Irinotecan Followed by Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients with Solid Tumors. Clinical Cancer Research. 11(11). 4144–4150. 5 indexed citations

Posadas, Edwin M., James L. Gulley, Philip M. Arlen, et al.. (2005). A phase II study of BAY 43–9006 in patients with androgen-independent prostate cancer (AIPC) with proteomic profiling. Journal of Clinical Oncology. 23(16_suppl). 4762–4762. 3 indexed citations

Grem, Jean L., Mary Quinn, Bruce Keith, et al.. (2003). A phase I and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorin. Cancer Chemotherapy and Pharmacology. 52(6). 487–496. 4 indexed citations

10.

Harold, Nancy, Muhammad Wasif Saif, Barbara Schüler, et al.. (2003). Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule. Cancer Chemotherapy and Pharmacology. 52(1). 79–85. 13 indexed citations

11.

Keith, Bruce, Suzanne Zentko, Nancy Harold, et al.. (2002). Impact of two weekly schedules of oral eniluracil given with fluorouracil and leucovorin on the duration of dihydropyrimidine dehydrogenase inhibition.. PubMed. 8(5). 1045–50. 4 indexed citations

12.

Grem, Jean L., Nancy Harold, Bruce Keith, et al.. (2002). A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients.. PubMed. 8(7). 2149–56. 7 indexed citations

13.

Grem, Jean L., Mary Quinn, Chris H. Takimoto, et al.. (2001). Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion. Cancer Chemotherapy and Pharmacology. 47(2). 117–125. 11 indexed citations

14.

Saif, Muhammad Wasif, et al.. (2001). Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracil. Anti-Cancer Drugs. 12(6). 525–531. 30 indexed citations

15.

Thomas, Rebecca R., William L. Dahut, Nancy Harold, et al.. (2001). A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients. Cancer Chemotherapy and Pharmacology. 48(3). 215–222. 11 indexed citations

16.

Grem, Jean L., Nancy Harold, Jeremy Shapiro, et al.. (2000). Phase I and Pharmacokinetic Trial of Weekly Oral Fluorouracil Given With Eniluracil and Low-Dose Leucovorin to Patients With Solid Tumors. Journal of Clinical Oncology. 18(23). 3952–3963. 20 indexed citations

17.

Shapiro, Jeremy, Nancy Harold, J. Michael Hamilton, et al.. (1999). A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.. PubMed. 5(9). 2399–408. 4 indexed citations

18.

Takimoto, Chris H., William L. Dahut, Mark T. Marino, et al.. (1997). Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients.. Journal of Clinical Oncology. 15(4). 1492–1501. 39 indexed citations

19.

Dahut, William L., Nancy Harold, Chris H. Takimoto, et al.. (1996). Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients.. Journal of Clinical Oncology. 14(4). 1236–1244. 61 indexed citations

20.

Otterson, Gregory A., Brian P. Monahan, Nancy Harold, et al.. (1996). Clinical significance of the FV:Q506 mutation in unselected oncology patients. The American Journal of Medicine. 101(4). 406–412. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact